Financial reports
10-K
2023 FY
Annual report
20 Feb 24
10-Q
2023 Q3
Quarterly report
7 Nov 23
10-Q
2023 Q2
Quarterly report
9 Aug 23
10-Q
2023 Q1
Quarterly report
11 May 23
10-K
2022 FY
Annual report
9 Mar 23
10-K/A
2021 FY
Annual report (amended)
21 Dec 22
10-Q
2022 Q3
Quarterly report
9 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
10-Q
2022 Q1
Quarterly report
11 May 22
10-K
2021 FY
Annual report
17 Mar 22
Current reports
8-K
Departure of Directors or Certain Officers
11 Apr 24
8-K
Departure of Directors or Certain Officers
3 Apr 24
8-K
Other Events
22 Mar 24
8-K
Barclays 26th Annual Global Healthcare Conference Dr. Maky Zanganeh Bob Duggan CEO & President Chairman & CEO
12 Mar 24
8-K
Other Events
5 Mar 24
8-K
Summit Therapeutics Reports Financial Results and Operational Progress
20 Feb 24
8-K
Oppenheimer’s 34th Annual Healthcare Life Sciences Conference Dr. Maky Zanganeh Bob Duggan CEO & President Chairman & CEO
15 Feb 24
8-K
Other Events
8 Feb 24
8-K
Results of Operations and Financial Condition
8 Jan 24
8-K
Other Events
3 Jan 24
Registration and prospectus
S-3
Shelf registration
20 Feb 24
S-3
Shelf registration
17 Mar 23
424B4
Prospectus supplement with pricing info
7 Feb 23
S-3/A
Shelf registration (amended)
20 Jan 23
S-3
Shelf registration
21 Dec 22
424B4
Prospectus supplement with pricing info
18 Jul 22
S-8
Registration of securities for employees
6 Apr 22
424B4
Prospectus supplement with pricing info
21 Apr 21
424B4
Prospectus supplement with pricing info
20 Jan 21
S-3
Shelf registration
8 Jan 21
Proxies
DEF 14A
Definitive proxy
25 Apr 24
DEF 14A
Definitive proxy
19 Sep 23
PRE 14A
Preliminary proxy
8 Sep 23
DEF 14A
Definitive proxy
21 Apr 23
DEF 14A
Definitive proxy
13 Dec 22
PRE 14A
Preliminary proxy
29 Nov 22
DEF 14A
Definitive proxy
7 Jul 22
PRE 14A
Preliminary proxy
24 Jun 22
DEFA14A
Additional proxy soliciting materials
3 Jun 22
DEF 14A
Definitive proxy
29 Apr 22
Other
EFFECT
Notice of effectiveness
28 Feb 24
EFFECT
Notice of effectiveness
28 Apr 23
CORRESP
Correspondence with SEC
25 Apr 23
UPLOAD
Letter from SEC
22 Mar 23
EFFECT
Notice of effectiveness
6 Feb 23
CORRESP
Correspondence with SEC
31 Jan 23
CORRESP
Correspondence with SEC
20 Jan 23
UPLOAD
Letter from SEC
12 Jan 23
CT ORDER
Confidential treatment order
14 Apr 22
CT ORDER
Confidential treatment order
14 Apr 22